Specialty Pharmacy

Clinical practice guideline on human papillomavirus (HPV) vaccination can improve prevention of cervical cancer.

Cancer-focused continuing education programs seek to enhance cancer care at specialty pharmacies.

Epic EHR system will be used among CVS Specialty Pharmacies.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses whether increased competition for specialty drugs can lower costs.

Antibody therapy enables efficacious control of HIV-like virus in monkeys.

Need for an increase in HCV testing awareness among health care providers and baby boomers.

Researchers will investigate factors that may contribute to poor cancer outcomes among African Americans.

Study links anti-tumor immunity to islet autoimmunity.

Top news of the day from across the health care landscape.

The risk of a second cancer remained high even 30 years after treatment.

Progression-free survival with IMMU-132 increases from an average of 3.5 months to 16.6 months in patients with breast cancer.

Round 2 of study finds a reduction in start time of antiretroviral therapy for HIV treatment.

TP53 alteration seen among 49% of patients receiving first-line treatment for renal cell carcinoma.

Test delivers the results of a multiple sclerosis diagnosis in as few as 7 days.

A double dose of inclisiran reduced LDL cholesterol up to 52.6%.

Top news of the day from across the health care landscape.

Discrepancies found when comparing real-world findings to clinical trial findings.

Preliminary trial finds moderate-intensity exercise does not increase adverse events in this patient population.

Researchers sought to change the volume of fatty deposits in a coronary artery that was at least 30% blocked.

Study compares common treatment options to prevent recurrent venous thromboembolism.

Top news of the week in oncology and cancer drug development.

Complications associated with left main bifurcation can impact stent choice.

A multi-faceted screening approach could prevent sudden cardiac deaths in young athletes.

Including warning labels may improve healthy eating habits.

Americans admitted to the hospital for heart failure have a 6% higher risk of dying than patients admitted in the spring.

Treatments have only increased 10% in hospitals nationwide over the past decade.

A self-expanding transcatheter aortic valve replacement (TAVR) procedure was just as effective as surgery in intermediate risk patients.

The Patient Navigator Program reduced readmission for heart attack or heart failure patients by 81.3%.

The PCSK9 inhibitor dramatically reduces high cholesterol and cuts the risk of heart attack and stroke.

The Blueprint for Transparency at the FDA provides 18 recommendations for the release of regulatory information and data.